Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

11 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Humoral Response to SARS-COV-2 Vaccination in Patients with Multiple Sclerosis and Neuromyelitis Optica Spectrum Disorder: A Real-World Study.
Millán-Pascual J, Valero-López G, Iniesta-Martinez F, Hellin-Gil MF, Jimenez-Veiga J, López-Tovar IA, Morales-Ortiz A, Meca-Lallana JE. Millán-Pascual J, et al. Among authors: valero lopez g. Neurol Ther. 2024 Feb;13(1):153-164. doi: 10.1007/s40120-023-00572-8. Epub 2023 Dec 14. Neurol Ther. 2024. PMID: 38097868 Free PMC article.
Corrigendum: Intrafamilial variability in SLC6A1-related neurodevelopmental disorders.
Kassabian B, Fenger CD, Willems M, Aledo-Serrano A, Linnankivi T, McDonnell PP, Lusk L, Jepsen BS, Bayat M, Kattentidt-Mouravieva AA, Vidal AA, Valero-Lopez G, Alarcon-Martinez H, Goodspeed K, van Slegtenhorst M, Barakat TS, Møller RS, Johannesen KM, Rubboli G. Kassabian B, et al. Among authors: valero lopez g. Front Neurosci. 2023 Aug 11;17:1270299. doi: 10.3389/fnins.2023.1270299. eCollection 2023. Front Neurosci. 2023. PMID: 37638311 Free PMC article.
Intrafamilial variability in SLC6A1-related neurodevelopmental disorders.
Kassabian B, Fenger CD, Willems M, Aledo-Serrano A, Linnankivi T, McDonnell PP, Lusk L, Jepsen BS, Bayat M, Kattentidt A, Vidal AA, Valero-Lopez G, Alarcon-Martinez H, Goodspeed K, van Slegtenhorst M, Barakat TS, Møller RS, Johannesen KM, Rubboli G. Kassabian B, et al. Among authors: valero lopez g. Front Neurosci. 2023 Jul 12;17:1219262. doi: 10.3389/fnins.2023.1219262. eCollection 2023. Front Neurosci. 2023. PMID: 37502687 Free PMC article.
Treatment with natalizumab during pregnancy in multiple sclerosis: The experience of implementing a clinical practice protocol (NAP-30).
Valero-López G, Millán-Pascual J, Iniesta-Martínez F, Delgado-Marín JL, Jimenez-Veiga J, Tejero-Martín AB, León-Hernández A, Zamarro-Parra J, Morales-Ortiz A, Meca-Lallana JE. Valero-López G, et al. Mult Scler Relat Disord. 2022 Oct;66:104038. doi: 10.1016/j.msard.2022.104038. Epub 2022 Jul 7. Mult Scler Relat Disord. 2022. PMID: 35870370 Free article.
Baseline Inflammatory Status Reveals Dichotomic Immune Mechanisms Involved In Primary-Progressive Multiple Sclerosis Pathology.
Fernández-Velasco JI, Monreal E, Kuhle J, Meca-Lallana V, Meca-Lallana J, Izquierdo G, Oreja-Guevara C, Gascón-Giménez F, Sainz de la Maza S, Walo-Delgado PE, Lapuente-Suanzes P, Maceski A, Rodríguez-Martín E, Roldán E, Villarrubia N, Saiz A, Blanco Y, Diaz-Pérez C, Valero-López G, Diaz-Diaz J, Aladro Y, Brieva L, Íñiguez C, González-Suárez I, Rodríguez de Antonio LA, García-Domínguez JM, Sabin J, Llufriu S, Masjuan J, Costa-Frossard L, Villar LM. Fernández-Velasco JI, et al. Among authors: valero lopez g. Front Immunol. 2022 Mar 21;13:842354. doi: 10.3389/fimmu.2022.842354. eCollection 2022. Front Immunol. 2022. PMID: 35386690 Free PMC article.
Erratum to "Pulse immunosuppressive therapy for multiple sclerosis during the SARS-CoV-2 lockdown de-escalation plan: Safety algorithm" [Neurologia. 2020;35(6):357-362].
Valero-López G, Carreón-Guarnizo E, Hernández-Clares R, Iniesta-Martínez F, Jiménez-Veiga J, Moreno-Docon A, Iborra-Bendicho MA, Aznar-Robles E, Hellín-Gil MF, Morales-Ortiz A, Meca-Lallana JE. Valero-López G, et al. Neurologia (Engl Ed). 2020 Sep;35(7):541. doi: 10.1016/j.nrl.2020.07.011. Neurologia (Engl Ed). 2020. PMID: 32800282 Free PMC article. English, Spanish. No abstract available.
Prevention of rebound effect after natalizumab withdrawal in multiple sclerosis. Study of two high-dose methylprednisolone schedules.
Fuentes-Rumí L, Hernández-Clares R, Carreón-Guarnizo E, Valero-López G, Iniesta-Martinez F, Cabrera-Maqueda JM, León-Hernández A, Zamarro-Parra J, Morales-Ortiz A, Meca-Lallana JE. Fuentes-Rumí L, et al. Among authors: valero lopez g. Mult Scler Relat Disord. 2020 Sep;44:102311. doi: 10.1016/j.msard.2020.102311. Epub 2020 Jun 20. Mult Scler Relat Disord. 2020. PMID: 32593958
Pulse immunosuppressive therapy for multiple sclerosis during the SARS-CoV-2 lockdown de-escalation plan: Safety algorithm.
Valero-López G, Carreón-Guarnizo E, Hernández-Clares R, Iniesta-Martínez F, Jiménez-Veiga J, Moreno-Docon A, Iborra-Bendicho MA, Aznar-Robles E, Hellín-Gil MF, Morales-Ortiz A, Meca-Lallana JE. Valero-López G, et al. Neurologia (Engl Ed). 2020 Jul-Aug;35(6):357-362. doi: 10.1016/j.nrl.2020.06.001. Epub 2020 Jun 8. Neurologia (Engl Ed). 2020. PMID: 32591152 Free PMC article. English, Spanish.
[Antibiotic diffusion to central nervous system].
Cabrera-Maqueda JM, Fuentes Rumí L, Valero López G, Baidez Guerrero AE, García Molina E, Díaz Pérez J, García-Vázquez E. Cabrera-Maqueda JM, et al. Among authors: valero lopez g. Rev Esp Quimioter. 2018 Feb;31(1):1-12. Epub 2018 Jan 31. Rev Esp Quimioter. 2018. PMID: 29390599 Free PMC article. Review. Spanish.
11 results